Transchromosomic Hens Producing Biotherapeutic Drugs

Award Information
Agency:
Department of Agriculture
Branch
n/a
Amount:
$80,000.00
Award Year:
2006
Program:
SBIR
Phase:
Phase I
Contract:
2006-33610-16842
Agency Tracking Number:
2006-00142
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
AviGenics, Inc.
111 Riverbend Rd., Athens, GA, 30605
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Dawn Eberhardt
(706) 227-1170
eberhardt@avigenics.com
Business Contact:
Jim Early
Senior Vice President
(206) 227-1170
jearly@avigenics.com
Research Institution:
n/a
Abstract
Basic science discoveries have led to the development of a series of human biotherapeutic drugs for the treatment of cancer and HIV as well as many other diseases. Currently there are over 400 drugs in clinical trials just for the first two diseases. The current biotherapeutics' manufacturing platforms have not kept pace resulting in a dramatic rise in treatment cost and more importantly unmet therapeutic needs. Avian transgenesis is an emerging technology that has the potential to radically increase the US manufacturing capacity of biotherapeuticals. AviGenics, Inc proposes a novel recombinant protein manufacturing platform that will allow us to express human therapeutic molecules in the egg white of hens.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government